In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
Stacker on MSN
New anxiety medications are in the pipeline for 2026
LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
New findings suggest that a protein known as Reelin could play a role in treating both “leaky gut” and severe depression.
Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...
Moment of Clarity has published a new educational resource on insurance coverage considerations for transcranial magnetic ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AbbVie is making a billion ...
A new review found that light to moderate intensity exercise may be better in tackling depression than vigorous exercise ...
Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...
Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...
About 13 percent of Americans have postpartum depression (PPD), a condition that occurs within the first year after childbirth. It’s one of the most common health issues pregnant people encounter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback